ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Avalo Therapeutics Inc

Avalo Therapeutics Inc (AVTX)

4,41
0,00
(0,00%)
Fermé 22 Avril 10:00PM
4,41
0,00
( 0,00% )
Avant marché: 2:46PM
Graphique avancé

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

Dernier
4,41
Prix Achat
3,95
Prix Vente
4,27
Volume échangé
399
0,00 Fourchette du Jour 0,00
4,15 Plage de 52 semaines 17,49
Cap du marché
Clôture Veille
4,41
Ouverture
-
Dernière Transaction
20
@
4.27
Dernière heure de transaction
15:09:23
Volume financier
-
VWAP
-
Volume moyen (3 m)
70 342
Actions en circulation
10 671 934
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,99
Bénéfice par action (BPA)
-2,96
Chiffre d'affairess
1,92M
Bénéfice net
-31,54M

À propos de Avalo Therapeutics Inc

Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
Siège social
Wilmington, Delaware, USA
Fondé
-
Avalo Therapeutics Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker AVTX. Le dernier cours de clôture d'Avalo Therapeutics était de US$4,41. Au cours de la dernière année, les actions de Avalo Therapeutics ont été négociées dans une fourchette de prix de US$ 4,15 à US$ 17,49.

Avalo Therapeutics compte actuellement 10 671 934 actions en circulation. La capitalisation boursière d'Avalo Therapeutics est de US$47,06 million. Avalo Therapeutics a un ratio cours/bénéfice (ratio PE) de -0.99.

AVTX Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.91-17.10526315795.325.854.151120474.70792635CS
4-4.06-47.93388429758.479.69994.15748896.33560854CS
12-2.78-38.66481223927.1911.234.15703427.30658601CS
26-6.84-60.811.25164.15841798.80040932CS
52-7.05-61.518324607311.4617.494.15540919.4572279CS
156-128.55-96.6832129964132.961711.23.9501791019734.61085673CS
260-684.39-99.3597560976688.81711.23.9501657385939.26979506CS

AVTX - Frequently Asked Questions (FAQ)

What is the current Avalo Therapeutics share price?
The current share price of Avalo Therapeutics is US$ 4,41
How many Avalo Therapeutics shares are in issue?
Avalo Therapeutics has 10 671 934 shares in issue
What is the market cap of Avalo Therapeutics?
The market capitalisation of Avalo Therapeutics is USD 47,06M
What is the 1 year trading range for Avalo Therapeutics share price?
Avalo Therapeutics has traded in the range of US$ 4,15 to US$ 17,49 during the past year
What is the PE ratio of Avalo Therapeutics?
The price to earnings ratio of Avalo Therapeutics is -0,99
What is the cash to sales ratio of Avalo Therapeutics?
The cash to sales ratio of Avalo Therapeutics is 16,25
What is the reporting currency for Avalo Therapeutics?
Avalo Therapeutics reports financial results in USD
What is the latest annual turnover for Avalo Therapeutics?
The latest annual turnover of Avalo Therapeutics is USD 1,92M
What is the latest annual profit for Avalo Therapeutics?
The latest annual profit of Avalo Therapeutics is USD -31,54M
What is the registered address of Avalo Therapeutics?
The registered address for Avalo Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Avalo Therapeutics website address?
The website address for Avalo Therapeutics is www.avalotx.com
Which industry sector does Avalo Therapeutics operate in?
Avalo Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
GELSGelteq Ltd
US$ 4,22
(368,89%)
44,47M
TIVCTivic Health Systems Inc
US$ 10,92
(212,00%)
10,32M
OBLGOblong Inc
US$ 4,23
(97,66%)
1,38M
WNWMeiwu Technology Company Ltd
US$ 2,03
(63,71%)
46,76M
ENTAEnanta Pharmaceuticals Inc
US$ 7,99
(52,77%)
8
VINCVincerx Pharma Inc
US$ 0,1244
(-54,76%)
424,99k
FORAForian Inc
US$ 1,02
(-46,03%)
4
MKDWMKDWELL Tech Inc
US$ 0,235
(-39,60%)
1,17M
DXRDaxor Corporation
US$ 5,01
(-37,22%)
2
HURCHurco Companies Inc
US$ 9,01
(-37,12%)
12
OCEAOcean Biomedical Inc
US$ 0,0422
(5,50%)
250,47M
WNWMeiwu Technology Company Ltd
US$ 2,03
(63,71%)
46,76M
GELSGelteq Ltd
US$ 4,22
(368,89%)
44,48M
DMNDamon Inc
US$ 0,00385
(-8,33%)
44,36M
DGLYDigital Ally Inc
US$ 0,027
(3,45%)
35,11M

AVTX Bilan

Bilan
Aucune Discussion Trouvée
Ajouter une Discussion